By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PrognosDx Health 

530 University Avenue

Palo Alto  California  94301  U.S.A.
Phone: 650-566-5068 Fax: n/a



Company News
I. Craig Henderson, M.D. Appointed Chairman Of The Board Of Directors At PrognosDx Health 1/21/2014 8:59:53 AM
PrognosDx Health Board of Directors Appoints Joseph J. Vallner, Ph.D. as Chief Executive Officer and Member of the Board of Directors 10/29/2013 12:31:24 PM
PrognosDx Health and Molecular Medicine Research Institute to Collaborate on Developing a New Class of Epigenetic Theranostics Initially Focused on Hormone Refractory Prostate Cancer 7/10/2013 11:02:35 AM
PrognosDx Health and Accium BioSciences, Inc. Enter Into Collaborative and Research Agreement to Develop Clinical Tests Based on Histone Biomarkers 10/25/2011 9:04:13 AM
Dr. Frank McCormick, Director of the UCSF Comprehensive Cancer Center and American Association for Cancer Research President-elect Joins as Ad-hoc Advisor to PrognosDx Health 9/29/2011 9:30:47 AM
PrognosDx Health Announces the Election of A. Franklin Rice to the Company’s Board of Directors 3/30/2011 9:19:02 AM
PrognosDx Health Announces Appointments of Dr. Garry Nolan to Board of Directors and Dr. Joseph Presti to Scientific Advisory Board 1/18/2011 10:37:00 AM
PrognosDx Health Announces Publication of Novel Epigenetic Study in Journal of Clinical Oncology 2/10/2010 10:13:28 AM
PrognosDx Health Granted Rights to University of California, Los Angeles (UCLA)'s Epigenetics Platform Technology 6/12/2009 9:26:10 AM